| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A bibliometric review of drug repurposing
|
Baker, Nancy C.
|
|
|
23 |
3 |
p. 661-672
|
artikel
|
| 2 |
Astrocytes as targets for drug discovery
|
Gorshkov, Kirill
|
|
|
23 |
3 |
p. 673-680
|
artikel
|
| 3 |
Contents page 1
|
|
|
|
23 |
3 |
p. i
|
artikel
|
| 4 |
Contents page 2
|
|
|
|
23 |
3 |
p. ii
|
artikel
|
| 5 |
Current attempts to implement microRNA-based diagnostics and therapy in cardiovascular and metabolic disease: a promising future
|
Thanikachalam, Punniyakoti Veeraveedu
|
|
|
23 |
3 |
p. 460-480
|
artikel
|
| 6 |
Drugs as habitable planets in the space of dark chemical matter
|
Siramshetty, Vishal B.
|
|
|
23 |
3 |
p. 481-486
|
artikel
|
| 7 |
Establishing rarity in the context of orphan medicinal product designation in the European Union
|
Tsigkos, Stelios
|
|
|
23 |
3 |
p. 681-686
|
artikel
|
| 8 |
Fixed-dose combinations: a potential means to boost drug development for selected drugs
|
Oo, Charles
|
|
|
23 |
3 |
p. 457-459
|
artikel
|
| 9 |
Incorporating upper motor neuron health in ALS drug discovery
|
Dervishi, Ina
|
|
|
23 |
3 |
p. 696-703
|
artikel
|
| 10 |
Increasing mtDNA levels as therapy for mitochondrial optic neuropathies
|
Ruiz-Pesini, Eduardo
|
|
|
23 |
3 |
p. 493-498
|
artikel
|
| 11 |
Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics
|
Zhou, Zhongxia
|
|
|
23 |
3 |
p. 503-518
|
artikel
|
| 12 |
Is preclinical data sharing the new norm?
|
Briggs, Katharine A.
|
|
|
23 |
3 |
p. 499-502
|
artikel
|
| 13 |
Ligandomics: a paradigm shift in biological drug discovery
|
Li, Wei
|
|
|
23 |
3 |
p. 636-643
|
artikel
|
| 14 |
Manipulating the epigenome for the treatment of disorders with thrombotic complications
|
Kwa, Faith A.A.
|
|
|
23 |
3 |
p. 719-726
|
artikel
|
| 15 |
Mechanism of nanoparticle-induced hypersensitivity in pigs: complement or not complement?
|
Szebeni, János
|
|
|
23 |
3 |
p. 487-492
|
artikel
|
| 16 |
Mimicking the 3D biology of osteochondral tissue with microfluidic-based solutions: breakthroughs towards boosting drug testing and discovery
|
Carvalho, Mariana R.
|
|
|
23 |
3 |
p. 711-718
|
artikel
|
| 17 |
NCp7: targeting a multitask protein for next-generation anti-HIV drug development part 2. Noncovalent inhibitors and nucleic acid binders
|
Iraci, Nunzio
|
|
|
23 |
3 |
p. 687-695
|
artikel
|
| 18 |
Network-based technologies for early drug discovery
|
Fotis, Chris
|
|
|
23 |
3 |
p. 626-635
|
artikel
|
| 19 |
On the glycosylation aspects of biosimilarity
|
Hajba, László
|
|
|
23 |
3 |
p. 616-625
|
artikel
|
| 20 |
Overcoming the resistance mechanisms of Smoothened inhibitors
|
Dong, Xiaochun
|
|
|
23 |
3 |
p. 704-710
|
artikel
|
| 21 |
Peripheral modulation of the endocannabinoid system in metabolic disease
|
Shrestha, Nirajan
|
|
|
23 |
3 |
p. 592-604
|
artikel
|
| 22 |
Pharmaceutical nanocrystals: production by wet milling and applications
|
Malamatari, Maria
|
|
|
23 |
3 |
p. 534-547
|
artikel
|
| 23 |
Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?
|
Mignani, Serge
|
|
|
23 |
3 |
p. 605-615
|
artikel
|
| 24 |
Privileged portal metastasis of hepatocellular carcinoma in light of co-evolution of a visceral portal system and the liver in the chordate lineage: a search for therapeutic targets
|
Subbotin, Vladimir M.
|
|
|
23 |
3 |
p. 548-564
|
artikel
|
| 25 |
Progress with covalent small-molecule kinase inhibitors
|
Zhao, Zheng
|
|
|
23 |
3 |
p. 727-735
|
artikel
|
| 26 |
Real world big data for clinical research and drug development
|
Singh, Gurparkash
|
|
|
23 |
3 |
p. 652-660
|
artikel
|
| 27 |
Safinamide: a new hope for Parkinson’s disease?
|
Teixeira, Fábio G.
|
|
|
23 |
3 |
p. 736-744
|
artikel
|
| 28 |
Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors
|
Singh, Mahaveer
|
|
|
23 |
3 |
p. 745-753
|
artikel
|
| 29 |
The diamond anniversary of tissue transglutaminase: a protein of many talents
|
Katt, William P.
|
|
|
23 |
3 |
p. 575-591
|
artikel
|
| 30 |
The hitchhiker’s guide to the chemical-biological galaxy
|
Opassi, Giulia
|
|
|
23 |
3 |
p. 565-574
|
artikel
|
| 31 |
Understanding missing proteins: a functional perspective
|
Zhou, Longjian
|
|
|
23 |
3 |
p. 644-651
|
artikel
|
| 32 |
Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery
|
Ahmad, Gulzar
|
|
|
23 |
3 |
p. 519-533
|
artikel
|
Tijdschrift beschrijving